MADRIGAL PHARMACEUTICALS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$430.36
-0.31%
Yahoo Finance · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-13.9%
3 months
-10.7%
6 months
-16.2%
1 year
+0.7%
Year to date
-26.1%
52-week range
$412.35 – $602.83
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$9.94B
P/E
-30.6
P/B
19
P/S
7.7
Revenue
$1.28B
Net income
-$325.1M
Diluted EPS
-12.85
Gross margin
91.50%
Net margin
-25.30%
Return on equity
-56.60%
Total debt
$347.75M
Cash
$292.88M
Free cash flow
-$209.29M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $364.25M | -$57.94M | 89.00% | -15.90% | $19.08M |
| Mar 31, 2026 | $311.34M | -$94.39M | 91.40% | -30.30% | -$171.28M |
| Dec 31, 2025 | $321.08M | -$58.58M | 92.40% | -18.20% | -$133.07M |
| Sep 30, 2025 | $287.27M | -$114.19M | 93.70% | -39.80% | $75.99M |
| Jun 30, 2025 | $212.8M | -$42.28M | 95.70% | -19.90% | -$47.05M |
| Mar 31, 2025 | $137.25M | -$73.24M | 96.70% | -53.40% | -$88.89M |
| Dec 31, 2024 | $103.32M | -$59.42M | 96.70% | -57.50% | -$104.68M |
| Sep 30, 2024 | $62.18M | -$106.96M | 96.50% | -172.00% | -$67.76M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent MDGL news
All market newsNo ticker-linked stories are in the current archive.